Best Agrolife Ltd
Best Agrolife Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
FY26 was challenging with a 31% YoY revenue decline to ₹1,257 crore; FY27 expected to improve. FY26 was challenging with reduced revenue and profits; FY27 expected to improve but no specific guidance provided.
From Best Agrolife Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- FY26 was challenging with a 31% YoY revenue decline to ₹1,257 crore; FY27 expected to improve.
- Price increases implemented in April and May 2026 expected to support profitability and top-line growth from Q1 FY27 onward.
- Deferred sales of ₹50-70 crore from March expected to reflect in Q1 FY27, leading to better turnover and profitability.
- Strategic focus on expanding B2B segment with new off-patent technical molecules in production, opening new revenue streams.
- Increased contribution from differentiated, patented products (40% of branded portfolio) to drive better margins.
- Introduction of biostimulant (bio-product) portfolio with 5 new products targeted at growth enhancement and yield improvement.
- Emphasis on operational efficiency, working capital optimization, and inventory reduction to support sustainable growth.
- No specific revenue guidance given, but management confident of stronger, more stable growth and better financial performance ahead.
Profitability & Margins
See what Best Agrolife Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company has postponed new capex planned for the existing plant as of FY26 and is putting it on hold (Page 7).
- Existing manufacturing capacity is currently sufficient and well-utilized (80-90% in season, 50-60% off-season) (Page 8).
- Setting up a similar manufacturing facility from scratch would require approximately ₹80-100 crore (Page 8).
- R&D spend will continue around 1% of sales, focusing on patented products and new patents (expecting 2-3 new patents in 2026-27) (Page 7).
- No immediate new large-scale capital investment is underway; focus remains on operational efficiency and working capital optimization (Page 5-7).
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Best Agrolife Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- No explicit mention of a current or expected order book or pending orders volume is found in the transcript.
- However, discussion indicates sales deferral of Rs. 50-70 crore from March to Q1 FY27 due to price revision expectations.
- Orders are expected to improve in Q1 FY27 with increased prices and better placements.
- The company is diversifying B2B segment with production of four new off-patent molecules starting Q1 FY27.
- Pricing actions and inventory management are expected to support gradual recovery and better cash flow going forward.
- Management indicated cautious manufacturing and procurement planning aligned with demand.
- Overall, company anticipates a stronger top line and profitability in the upcoming quarters supported by these strategic actions.
Best Agrolife Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹156 Cr, net loss ₹37 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Best Agrolife Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Indogulf Cropsciences Ltd (Q4 FY26)
Successful single order in Venezuela contributing approximately INR 4 crores in revenue, indicating active export orders. Key concall takeaways from Indogulf…
- Rallis India Ltd (Q4 FY26)
Crop Protection B2C business growth excluding Soil & Plant Health (SPH) will be marginally positive to low single digit; SPH segment grew robustly at 27%. Key…
- Punjab Chemicals & Crop Protection Ltd (Q4 FY26)
Overall volume growth in FY '26 was around 14%, primarily driven by new products. Key concall takeaways from Punjab Chemicals & Crop Protection Ltd's Q4 FY26…
- Krishana Phoschem Ltd (Q4 FY26)
The Company has recently completed a significant capacity expansion: NPK/DAP capacity increased by 50% to 495,000 MTPA, SSP capacity at 120,000 MTPA, totaling…
Frequently Asked Questions
What were Best Agrolife Ltd Q4 FY26 results?
FY26 was challenging with a 31% YoY revenue decline to ₹1,257 crore; FY27 expected to improve. FY26 was challenging with reduced revenue and profits; FY27 expected to improve but no specific guidance provided.
What is Best Agrolife Ltd share price analysis?
Best Agrolife Ltd currently shows a neutral. The stock trades at a P/E of 25.1 with a market cap of ₹743 Cr. Investors should review the full earnings analysis for detailed insights.
Is Best Agrolife Ltd planning capital expenditure?
The company has postponed new capex planned for the existing plant as of FY26 and is putting it on hold (Page 7).
Keep Best Agrolife Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.